The cheapest continuous glucose monitors currently available to US consumers are the over-the-counter biosensors Dexcom Stelo and Abbott Lingo, which start at roughly $50 for a single 15-day sensor. Prescription CGMs covered by insurance can be even less expensive out of pocket for people who qualify.
Why Price Ranges Are So Wide
CGM cost depends on three things: device type, insurance status, and use indication. The same underlying sensor chemistry sits inside products priced differently based on who the product is marketed to. A person with type 2 diabetes on insulin may pay a $15 monthly co-pay for Dexcom G7, while a non-diabetic fitness user pays $89 for Dexcom Stelo out of pocket. Understanding the segmentation helps you find the truly cheapest option for your situation.
Over-the-Counter CGMs in 2026
In March 2024 the FDA cleared Dexcom Stelo as the first OTC CGM in the United States. Abbott’s Lingo followed in the same year. Both target adults without diabetes who want to observe glucose patterns.
| Device | Prescription? | Sensor wear | Approx. single-sensor price | Monthly plan |
|---|---|---|---|---|
| Dexcom Stelo | No | 15 days | $89 | ~$99 for 2 sensors |
| Abbott Lingo | No | 14 days | $49 | $89 for 2 sensors |
| FreeStyle Libre 2 Plus | Yes | 15 days | $75 | Variable with insurance |
| FreeStyle Libre 3 | Yes | 14-15 days | $75-90 | Co-pay often $25-60 |
| Dexcom G7 | Yes | 10 days | $90 | Co-pay often $35-75 |
Prices change frequently. Always verify current pricing on the manufacturer’s site before ordering.
Accuracy Is Similar Across Options
Despite different price tags, mainstream CGMs perform comparably. Published mean absolute relative difference (MARD) values cluster between 8% and 10% across Dexcom G7, FreeStyle Libre 3, Stelo, and Lingo. For people with prediabetes looking at glucose trends, these differences are largely academic. For someone dosing rapid-acting insulin, small accuracy differences matter and should be discussed with a clinician.
What You Gain by Paying More
- Hypoglycemia alerts: OTC biosensors do not alarm at low glucose because they are not intended for users on insulin. Prescription CGMs do.
- Integration: G7 and Libre 3 integrate with insulin pumps and automated insulin delivery systems.
- Clinical dashboards: Prescription devices upload to clinician portals for review at visits.
- FDA indication: Prescription devices are cleared for treatment decisions; OTC devices are cleared for wellness insights.
Who Should Consider Which
If you have diabetes (type 1, type 2, or gestational) and use insulin, the cheapest effective option is usually a prescription CGM billed through insurance. Your endocrinologist or primary care clinician can write the prescription and submit prior authorization.
If you have prediabetes or are curious about glucose response to meals and exercise, an OTC device is adequate. Pair the data with a structured prediabetes nutrition plan and retest labs like A1C and fasting insulin to confirm improvements.
How to Use a Cheap CGM Effectively
- Pick a baseline week before changing diet or exercise, to establish your usual patterns.
- Log meals and activity with timestamps in the companion app.
- Look at patterns, not single numbers – time in range, post-meal peaks, overnight stability.
- Interpret with a clinician if you see concerning highs, lows, or post-meal spikes above 180 mg/dL.
Hidden Costs to Watch
Sensor replacement is the recurring expense, but consider also: smartphone compatibility (older phones may not run the latest apps), adhesive overlays in hot or humid climates, skin reactions requiring barrier films, and subscription auto-renewals that are easy to forget to cancel.
Ways to Lower CGM Costs Further
- Manufacturer savings programs: Abbott and Dexcom both run patient-assistance programs that reduce retail price for qualifying patients who are uninsured or under-insured.
- HSA and FSA dollars: Both prescription and OTC CGMs are eligible for health savings and flexible spending accounts, effectively shaving 20-30% off with pre-tax dollars.
- Multi-sensor bundles: Stelo and Lingo offer small discounts when you subscribe to monthly or quarterly deliveries rather than one-off purchases.
- Ask about GoodRx and manufacturer coupons for prescription CGMs – they sometimes beat the pharmacy-benefit price for self-pay customers.
- Durable medical equipment benefit: Some plans cover CGM under DME rather than pharmacy, which can be cheaper depending on deductible status.
Cheap Does Not Always Mean Best
The lowest-priced option is the right choice only if it matches your use case. For a person with type 2 diabetes on a sulfonylurea who needs hypoglycemia alerts, an OTC device without low-glucose alarms may cost more in the long run through preventable adverse events. For a wellness-curious adult with no diabetes risk factors, a two-week trial of Lingo is probably more than enough to learn personal glucose patterns without committing to ongoing spend.
The Bottom Line
The cheapest continuous glucose monitor for you depends on whether you have a qualifying diagnosis and insurance coverage. For self-pay consumers, Abbott Lingo is the current low-price leader, followed by Dexcom Stelo. For insured people with diabetes, a prescription CGM through pharmacy benefit is almost always cheaper than OTC biosensors. Accuracy is similar across devices – choose based on features you need, not marketing price alone. Consult a clinician before changing any medication based on CGM data, especially insulin or other diabetes treatments.
